Tsumoru Miyamoto
- Pharmacology top 1%
- Molecular Biology
- Biochemistry top 1%
- Physiology top 10%
- Genetics top 10%
- Co-authors
- Osamu HayaishiN OginoShogo YamamotoMasaaki TodaKatsuhiro ImakiMasafumi SugitaniKazuhito KawabataMayumi Suzuki
- Topics
- Eicosanoids and Hypertension Pharmacology (5 papers)Inflammatory mediators and NSAID effects (5 papers)Asthma and respiratory diseases (5 papers)
- Cited by
- BiochemistryPharmacology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryBiochemical and Biophysical Research Communications
- Partner nations
- JapanSwedenUnited States
In The Last Decade
Tsumoru Miyamoto
22 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Pharmacology 670
- Molecular Biology 489
- Biochemistry 406
- Physiology 297
- Genetics 209
Countries citing papers authored by Tsumoru Miyamoto
This map shows the geographic impact of Tsumoru Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsumoru Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsumoru Miyamoto more than expected).
Fields of papers citing papers by Tsumoru Miyamoto
This network shows the impact of papers produced by Tsumoru Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsumoru Miyamoto. The network helps show where Tsumoru Miyamoto may publish in the future.
Co-authorship network of co-authors of Tsumoru Miyamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Tsumoru Miyamoto. A scholar is included among the top collaborators of Tsumoru Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsumoru Miyamoto. Tsumoru Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 36 | |
| 3 | Effect of leukotriene antagonist on experimental and clinical bronchial asthma. | 5 |
| 4 | 313 | |
| 5 | ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist. | 19 |
| 6 | 74 | |
| 7 | 35 | |
| 8 | Production and binding of leukotrienes in the rat brain. | 2 |
| 9 | Formation of lipoxygenase products in the rat brain. | 8 |
| 10 | 50 | |
| 11 | 51 | |
| 12 | New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347. | 24 |
| 13 | 27 | |
| 14 | 99 | |
| 15 | 51 | |
| 16 | 82 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 20 | |
| 20 | 88 |
About Tsumoru Miyamoto
Tsumoru Miyamoto is a scholar working on Biochemistry, Pharmacology and Pharmacology, having authored 22 papers that have together received 1.7k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Biochemistry (406 citations), Pharmacology (670 citations) and Pharmacology (156 citations). Tsumoru Miyamoto has collaborated with scholars based in Japan, Sweden and United States. Frequent co-authors include Osamu Hayaishi, N Ogino, Shogo Yamamoto, Masaaki Toda, Katsuhiro Imaki, Masafumi Sugitani, Kazuhito Kawabata, Mayumi Suzuki, Shozo Yamamoto and Yukio Maeda. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.